Trial Intelligence

Feasibility benchmarks from every industry trial on the register.

Type an indication. Get the enrollment, duration and site benchmarks your protocol assumptions should be built on, plus the design precedents and the competitive landscape. Runs entirely in your browser.

, industry trials, 2010, present

, indications indexed

ClinicalTrials.govpublic domain source

New HTA Outcomes: 12,000+ decisions from sixteen agencies, searchable by molecule ›

Try: psoriasis atopic dermatitis type 2 diabetes obesity rheumatoid arthritis migraine

Loading trial database…

Feasibility benchmarks

		Patients enrolled			Duration (months)			Sites
Phase	Trials	p25	median	p75	p25	median	p75	median	pts / site

Patients enrolled: Actual enrolled participants at trial completion (not the sponsor's original target).
Duration: Months from study start to primary completion: the primary-endpoint readout, not final follow-up or database lock.
Sites: Registered investigator sites. Pts/site is patients ÷ sites, the recruitment rate your site plan implies.
p25 / median / p75: Quartiles across the matching trials: a quarter came in below p25, half below the median, a quarter above p75.

Sponsor landscape

Lead industry sponsors, trials started 2020 onward

Sponsor	Trials		Ph3

Design patterns

Phase 2-3 trials since 2018

Design precedents

NCT ID	Phase	Patients	Sites	Countries	Months	Design	Sponsor	Started

Full precedent tables, exports and bespoke cuts

This page shows the top of each result. Client access adds the complete precedent list for any indication, CSV/Excel export, site-and-country breakdowns, and comparator sets built to your protocol question, plus post-approval uptake curves from national prescribing data.

Request access Or send us a feasibility question and we'll answer it from the data.